NEW YORK (GenomeWeb News) – Vermillion today said that its unsecured creditors have "overwhelmingly accepted" its First Amended Chapter 11 Plan of Reorganization.

Approval of the plan clears the way for the Fremont, Calif.-based molecular diagnostics firm to proceed to a confirmation hearing for the plan before the US Bankruptcy Court for the District of Delaware. That confirmation hearing is scheduled for tomorrow, Jan. 7.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.